BACKGROUND: There has been no study to investigate whether cystatin C could predict cardiovascular events in incident dialysis patients. We aimed to delineate the role of serum cystatin C and cystatin C-based estimated glomerular filtration rate (eGFR(cysC)) for prediction of cardiovascular events. METHODS: This study included 66 end-stage renal disease patients who survived for >3 months after the start of dialysis, and serum cystain C levels were measured at the point of dialysis initiation. RESULTS: Serum cystatin C was correlated with blood urea nitrogen (r = 0.537, p < 0.001), serum creatinine (r = 0.480, p < 0.001) and smoking (r = 0.284, p = 0.021). Cystatin C was inversely correlated with age (r = -0.316, p = 0.01) and eGFR(Cr) by modification of diet in renal disease (r = -0.533, p < 0.001). Kaplan-Meier analysis for cardiovascular events revealed that patients in the group with lower cystatin C levels (<4.14 mg/L) had a better event-free survival rate than patients in the group with higher cystatin C levels (≥4.14 mg/L) (p = 0.039). In univariate analysis, cystatin C (hazard ratio (HR) 2.62, p = 0.011) and eGFR(cysC) (HR 0.64, p = 0.004) were significant factors for the prediction of cardiovascular events. After multivariate adjustment, serum cystatin C and eGFR(cysC) were independent determinants of cardiovascular events (HR 3.952, p = 0.001 and HR 0.640, p = 0.004, respectively). CONCLUSION: Serum cystatin C might be an independent marker of cardiovascular events in incident dialysis patients. Furthermore, eGFR(cysC) based on measured serum cystatin C could have a new role in predicting cardiovascular events beyond the estimation of true GFR.
BACKGROUND: There has been no study to investigate whether cystatin C could predict cardiovascular events in incident dialysis patients. We aimed to delineate the role of serum cystatin C and cystatin C-based estimated glomerular filtration rate (eGFR(cysC)) for prediction of cardiovascular events. METHODS: This study included 66 end-stage renal diseasepatients who survived for >3 months after the start of dialysis, and serum cystain C levels were measured at the point of dialysis initiation. RESULTS: Serum cystatin C was correlated with blood ureanitrogen (r = 0.537, p < 0.001), serum creatinine (r = 0.480, p < 0.001) and smoking (r = 0.284, p = 0.021). Cystatin C was inversely correlated with age (r = -0.316, p = 0.01) and eGFR(Cr) by modification of diet in renal disease (r = -0.533, p < 0.001). Kaplan-Meier analysis for cardiovascular events revealed that patients in the group with lower cystatin C levels (<4.14 mg/L) had a better event-free survival rate than patients in the group with higher cystatin C levels (≥4.14 mg/L) (p = 0.039). In univariate analysis, cystatin C (hazard ratio (HR) 2.62, p = 0.011) and eGFR(cysC) (HR 0.64, p = 0.004) were significant factors for the prediction of cardiovascular events. After multivariate adjustment, serum cystatin C and eGFR(cysC) were independent determinants of cardiovascular events (HR 3.952, p = 0.001 and HR 0.640, p = 0.004, respectively). CONCLUSION: Serum cystatin C might be an independent marker of cardiovascular events in incident dialysis patients. Furthermore, eGFR(cysC) based on measured serum cystatin C could have a new role in predicting cardiovascular events beyond the estimation of true GFR.
Authors: Constantijn J A M Konings; Marc Hermans; Jeroen P Kooman; Jan M Meinders; Arnold P G Hoeks; Frank M van der Sande; Karel M L Leunissen Journal: Perit Dial Int Date: 2004 Jul-Aug Impact factor: 1.756
Authors: David Singh; Mary A Whooley; Joachim H Ix; Sadia Ali; Michael G Shlipak Journal: Nephrol Dial Transplant Date: 2007-01-08 Impact factor: 5.992
Authors: Vandana Menon; Michael G Shlipak; Xuelei Wang; Josef Coresh; Tom Greene; Lesley Stevens; John W Kusek; Gerald J Beck; Allan J Collins; Andrew S Levey; Mark J Sarnak Journal: Ann Intern Med Date: 2007-07-03 Impact factor: 25.391
Authors: Tariq Shafi; Rulan S Parekh; Bernard G Jaar; Laura C Plantinga; Pooja C Oberai; John H Eckfeldt; Andrew S Levey; Neil R Powe; Josef Coresh Journal: Clin J Am Soc Nephrol Date: 2012-06-28 Impact factor: 8.237
Authors: Olivera Marsenic; Andrea Wierenga; Donna R Wilson; Michael Anderson; Tripti Shrivastava; Garfield A Simon; Anne M Beck; Tiffany J Swanson; Kathleen Studnicka; Dorit Elberg; Kevin Couloures; Martin A Turman Journal: Pediatr Nephrol Date: 2012-11-21 Impact factor: 3.714
Authors: Stefanie W Benoit; Thelma Kathman; Jay Patel; Melinda Stegman; Cristina Cobb; Jonathan Hoehn; Prasad Devarajan; Edward J Nehus Journal: Kidney Int Rep Date: 2020-12-07